PGC-1β mediates adaptive chemoresistance associated with mitochondrial DNA mutations

Z. Yao, A. W.E. Jones, E. Fassone, M. G. Sweeney, M. Lebiedzinska, J. M. Suski, M. R. Wieckowski, N. Tajeddine, I. P. Hargreaves, T. Yasukawa, G. Tufo, C. Brenner, G. Kroemer, S. Rahman, G. Szabadkai

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Primary mitochondrial dysfunction commonly leads to failure in cellular adaptation to stress. Paradoxically, however, nonsynonymous mutations of mitochondrial DNA (mtDNA) are frequently found in cancer cells and may have a causal role in the development of resistance to genotoxic stress induced by common chemotherapeutic agents, such as cis-diammine-dichloroplatinum(II) (cisplatin, CDDP). Little is known about how these mutations arise and the associated mechanisms leading to chemoresistance. Here, we show that the development of adaptive chemoresistance in the A549 non-small-cell lung cancer cell line to CDDP is associated with the hetero- to homoplasmic shift of a nonsynonymous mutation in MT-ND2, encoding the mitochondrial Complex-I subunit ND2. The mutation resulted in a 50% reduction of the NADH:ubiquinone oxidoreductase activity of the complex, which was compensated by increased biogenesis of respiratory chain complexes. The compensatory mitochondrial biogenesis was most likely mediated by the nuclear co-activators peroxisome proliferator-activated receptor gamma co-activator-1α (PGC-1α) and PGC-1β, both of which were significantly upregulated in the CDDP-resistant cells. Importantly, both transient and stable silencing of PGC-1β re-established the sensitivity of these cells to CDDP-induced apoptosis. Remarkably, the PGC-1β-mediated CDDP resistance was independent of the mitochondrial effects of the co-activator. Altogether, our results suggest that partial respiratory chain defects because of mtDNA mutations can lead to compensatory upregulation of nuclear transcriptional co-regulators, in turn mediating resistance to genotoxic stress.

Original languageEnglish
Pages (from-to)2592-2600
Number of pages9
JournalOncogene
Volume32
Issue number20
DOIs
Publication statusPublished - May 16 2013

Fingerprint

Mitochondrial DNA
Mutation
Electron Transport
DNA Damage
Electron Transport Complex I
PPAR gamma
Organelle Biogenesis
Non-Small Cell Lung Carcinoma
Cisplatin
Up-Regulation
Apoptosis
Cell Line
Neoplasms

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Yao, Z., Jones, A. W. E., Fassone, E., Sweeney, M. G., Lebiedzinska, M., Suski, J. M., ... Szabadkai, G. (2013). PGC-1β mediates adaptive chemoresistance associated with mitochondrial DNA mutations. Oncogene, 32(20), 2592-2600. https://doi.org/10.1038/onc.2012.259

PGC-1β mediates adaptive chemoresistance associated with mitochondrial DNA mutations. / Yao, Z.; Jones, A. W.E.; Fassone, E.; Sweeney, M. G.; Lebiedzinska, M.; Suski, J. M.; Wieckowski, M. R.; Tajeddine, N.; Hargreaves, I. P.; Yasukawa, T.; Tufo, G.; Brenner, C.; Kroemer, G.; Rahman, S.; Szabadkai, G.

In: Oncogene, Vol. 32, No. 20, 16.05.2013, p. 2592-2600.

Research output: Contribution to journalArticle

Yao, Z, Jones, AWE, Fassone, E, Sweeney, MG, Lebiedzinska, M, Suski, JM, Wieckowski, MR, Tajeddine, N, Hargreaves, IP, Yasukawa, T, Tufo, G, Brenner, C, Kroemer, G, Rahman, S & Szabadkai, G 2013, 'PGC-1β mediates adaptive chemoresistance associated with mitochondrial DNA mutations', Oncogene, vol. 32, no. 20, pp. 2592-2600. https://doi.org/10.1038/onc.2012.259
Yao Z, Jones AWE, Fassone E, Sweeney MG, Lebiedzinska M, Suski JM et al. PGC-1β mediates adaptive chemoresistance associated with mitochondrial DNA mutations. Oncogene. 2013 May 16;32(20):2592-2600. https://doi.org/10.1038/onc.2012.259
Yao, Z. ; Jones, A. W.E. ; Fassone, E. ; Sweeney, M. G. ; Lebiedzinska, M. ; Suski, J. M. ; Wieckowski, M. R. ; Tajeddine, N. ; Hargreaves, I. P. ; Yasukawa, T. ; Tufo, G. ; Brenner, C. ; Kroemer, G. ; Rahman, S. ; Szabadkai, G. / PGC-1β mediates adaptive chemoresistance associated with mitochondrial DNA mutations. In: Oncogene. 2013 ; Vol. 32, No. 20. pp. 2592-2600.
@article{380be5ab1d3440d5ad1ce4b23ebac4f4,
title = "PGC-1β mediates adaptive chemoresistance associated with mitochondrial DNA mutations",
abstract = "Primary mitochondrial dysfunction commonly leads to failure in cellular adaptation to stress. Paradoxically, however, nonsynonymous mutations of mitochondrial DNA (mtDNA) are frequently found in cancer cells and may have a causal role in the development of resistance to genotoxic stress induced by common chemotherapeutic agents, such as cis-diammine-dichloroplatinum(II) (cisplatin, CDDP). Little is known about how these mutations arise and the associated mechanisms leading to chemoresistance. Here, we show that the development of adaptive chemoresistance in the A549 non-small-cell lung cancer cell line to CDDP is associated with the hetero- to homoplasmic shift of a nonsynonymous mutation in MT-ND2, encoding the mitochondrial Complex-I subunit ND2. The mutation resulted in a 50{\%} reduction of the NADH:ubiquinone oxidoreductase activity of the complex, which was compensated by increased biogenesis of respiratory chain complexes. The compensatory mitochondrial biogenesis was most likely mediated by the nuclear co-activators peroxisome proliferator-activated receptor gamma co-activator-1α (PGC-1α) and PGC-1β, both of which were significantly upregulated in the CDDP-resistant cells. Importantly, both transient and stable silencing of PGC-1β re-established the sensitivity of these cells to CDDP-induced apoptosis. Remarkably, the PGC-1β-mediated CDDP resistance was independent of the mitochondrial effects of the co-activator. Altogether, our results suggest that partial respiratory chain defects because of mtDNA mutations can lead to compensatory upregulation of nuclear transcriptional co-regulators, in turn mediating resistance to genotoxic stress.",
author = "Z. Yao and Jones, {A. W.E.} and E. Fassone and Sweeney, {M. G.} and M. Lebiedzinska and Suski, {J. M.} and Wieckowski, {M. R.} and N. Tajeddine and Hargreaves, {I. P.} and T. Yasukawa and G. Tufo and C. Brenner and G. Kroemer and S. Rahman and G. Szabadkai",
year = "2013",
month = "5",
day = "16",
doi = "10.1038/onc.2012.259",
language = "English",
volume = "32",
pages = "2592--2600",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "20",

}

TY - JOUR

T1 - PGC-1β mediates adaptive chemoresistance associated with mitochondrial DNA mutations

AU - Yao, Z.

AU - Jones, A. W.E.

AU - Fassone, E.

AU - Sweeney, M. G.

AU - Lebiedzinska, M.

AU - Suski, J. M.

AU - Wieckowski, M. R.

AU - Tajeddine, N.

AU - Hargreaves, I. P.

AU - Yasukawa, T.

AU - Tufo, G.

AU - Brenner, C.

AU - Kroemer, G.

AU - Rahman, S.

AU - Szabadkai, G.

PY - 2013/5/16

Y1 - 2013/5/16

N2 - Primary mitochondrial dysfunction commonly leads to failure in cellular adaptation to stress. Paradoxically, however, nonsynonymous mutations of mitochondrial DNA (mtDNA) are frequently found in cancer cells and may have a causal role in the development of resistance to genotoxic stress induced by common chemotherapeutic agents, such as cis-diammine-dichloroplatinum(II) (cisplatin, CDDP). Little is known about how these mutations arise and the associated mechanisms leading to chemoresistance. Here, we show that the development of adaptive chemoresistance in the A549 non-small-cell lung cancer cell line to CDDP is associated with the hetero- to homoplasmic shift of a nonsynonymous mutation in MT-ND2, encoding the mitochondrial Complex-I subunit ND2. The mutation resulted in a 50% reduction of the NADH:ubiquinone oxidoreductase activity of the complex, which was compensated by increased biogenesis of respiratory chain complexes. The compensatory mitochondrial biogenesis was most likely mediated by the nuclear co-activators peroxisome proliferator-activated receptor gamma co-activator-1α (PGC-1α) and PGC-1β, both of which were significantly upregulated in the CDDP-resistant cells. Importantly, both transient and stable silencing of PGC-1β re-established the sensitivity of these cells to CDDP-induced apoptosis. Remarkably, the PGC-1β-mediated CDDP resistance was independent of the mitochondrial effects of the co-activator. Altogether, our results suggest that partial respiratory chain defects because of mtDNA mutations can lead to compensatory upregulation of nuclear transcriptional co-regulators, in turn mediating resistance to genotoxic stress.

AB - Primary mitochondrial dysfunction commonly leads to failure in cellular adaptation to stress. Paradoxically, however, nonsynonymous mutations of mitochondrial DNA (mtDNA) are frequently found in cancer cells and may have a causal role in the development of resistance to genotoxic stress induced by common chemotherapeutic agents, such as cis-diammine-dichloroplatinum(II) (cisplatin, CDDP). Little is known about how these mutations arise and the associated mechanisms leading to chemoresistance. Here, we show that the development of adaptive chemoresistance in the A549 non-small-cell lung cancer cell line to CDDP is associated with the hetero- to homoplasmic shift of a nonsynonymous mutation in MT-ND2, encoding the mitochondrial Complex-I subunit ND2. The mutation resulted in a 50% reduction of the NADH:ubiquinone oxidoreductase activity of the complex, which was compensated by increased biogenesis of respiratory chain complexes. The compensatory mitochondrial biogenesis was most likely mediated by the nuclear co-activators peroxisome proliferator-activated receptor gamma co-activator-1α (PGC-1α) and PGC-1β, both of which were significantly upregulated in the CDDP-resistant cells. Importantly, both transient and stable silencing of PGC-1β re-established the sensitivity of these cells to CDDP-induced apoptosis. Remarkably, the PGC-1β-mediated CDDP resistance was independent of the mitochondrial effects of the co-activator. Altogether, our results suggest that partial respiratory chain defects because of mtDNA mutations can lead to compensatory upregulation of nuclear transcriptional co-regulators, in turn mediating resistance to genotoxic stress.

UR - http://www.scopus.com/inward/record.url?scp=84878015925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878015925&partnerID=8YFLogxK

U2 - 10.1038/onc.2012.259

DO - 10.1038/onc.2012.259

M3 - Article

C2 - 22777349

AN - SCOPUS:84878015925

VL - 32

SP - 2592

EP - 2600

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 20

ER -